182 related articles for article (PubMed ID: 1969247)
21. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
[TBL] [Abstract][Full Text] [Related]
22. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
Adler LA; Peselow E; Duncan E; Rosenthal M; Angrist B
Psychopharmacol Bull; 1993; 29(3):371-4. PubMed ID: 8121964
[TBL] [Abstract][Full Text] [Related]
24. Is melatonin treatment effective for tardive dyskinesia?
Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
[TBL] [Abstract][Full Text] [Related]
25. Treatment of tardive dyskinesia with propranolol.
Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
[TBL] [Abstract][Full Text] [Related]
26. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial.
Emsley R; Niehaus DJ; Koen L; Oosthuizen PP; Turner HJ; Carey P; van Rensburg SJ; Maritz JS; Murck H
Schizophr Res; 2006 May; 84(1):112-20. PubMed ID: 16632329
[TBL] [Abstract][Full Text] [Related]
27. A crossover study of lecithin treatment of tardive dyskinesia.
Gelenberg AJ; Dorer DJ; Wojcik JD; Falk WE; Brotman AW; Leahy L
J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
[TBL] [Abstract][Full Text] [Related]
28. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
29. [Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders].
Miodownik C; Cohen H; Kotler M; Lerner V
Harefuah; 2003 Sep; 142(8-9):592-6, 647. PubMed ID: 14518160
[TBL] [Abstract][Full Text] [Related]
30. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
Stacy M; Sajatovic M; Kane JM; Cutler AJ; Liang GS; O'Brien CF; Correll CU
Mov Disord; 2019 Aug; 34(8):1203-1209. PubMed ID: 31234240
[TBL] [Abstract][Full Text] [Related]
31. Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C.
Michael N; Sourgens H; Arolt V; Erfurth A
Neuropsychobiology; 2002; 46 Suppl 1():28-30. PubMed ID: 12571430
[TBL] [Abstract][Full Text] [Related]
32. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
33. Vitamin E in the treatment of tardive dyskinesia: a replication study.
Lam LC; Chiu HF; Hung SF
J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529
[No Abstract] [Full Text] [Related]
34. Oxidative mechanisms and tardive dyskinesia.
Lohr JB; Kuczenski R; Niculescu AB
CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
[TBL] [Abstract][Full Text] [Related]
35. [Tardive dyskinesia: pergolid, a possible therapeutic option].
Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
37. Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.
Loonen AJ; Verwey HA; Roels PR; van Bavel LP; Doorschot CH
J Clin Psychopharmacol; 1992 Feb; 12(1):39-42. PubMed ID: 1348061
[TBL] [Abstract][Full Text] [Related]
38. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
Xu H; Qin H; Chen S; Guan M
Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
[TBL] [Abstract][Full Text] [Related]
39. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
Dorevitch A; Lerner V; Shalfman M; Kalian M
Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
[TBL] [Abstract][Full Text] [Related]
40. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia.
Browne J; Silver H; Martin R; Hart R; Mergener M; Williams P
J Clin Psychopharmacol; 1986 Apr; 6(2):88-92. PubMed ID: 2871058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
